<DOC>
	<DOCNO>NCT00000483</DOCNO>
	<brief_summary>To determine whether long term sequela drug use Coronary Drug Project ( estrogen , dextrothyroxine , nicotinic acid , clofibrate ) .</brief_summary>
	<brief_title>Coronary Drug Project Mortality Surveillance</brief_title>
	<detailed_description>BACKGROUND : Three CDP treatment ( two dos estrogen dextrothyroxine ) stop prematurely toxicity . At time treatment stop , thought future assessment status patient treatment would important evaluate long-term sequellae . Another clinical trial evaluate clofibrate primary prevention find patient treatment placebo die . This effect persist even treatment stop . Therefore , consider necessary follow CDP patient clofibrate . Of original 834l patient , 6000 still alive March l975 . Cause-specific mortality patient assess March l980 . DESIGN NARRATIVE : The vital status subject know alive end CDP March l975 assess March l980 . This accomplish question local investigator , letter subject , use Social Security Administration National Death Index record . The study completion date list record obtain Query/View/Report ( QVR ) System .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<mesh_term>Clofibrate</mesh_term>
	<criteria>No eligibility criterion</criteria>
	<gender>Male</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>April 2004</verification_date>
</DOC>